Stanford University
Showing 5,481-5,500 of 34,489 Results
-
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
On Partial Leave from 2026-09-01 To 2027-08-31Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. is a Clinical Assistant Professor at Stanford University School of Medicine and Associate Chief Medical Officer and Vice President for Clinical Affairs, Quality, and Health Equity at Stanford Health Care – Tri-Valley.
Dr. Chu joined Tri-Valley as an academic hospitalist in 2015 after completing his internal medicine residency at Stanford. He served as a Clinical Instructor from 2015 to 2018 and has been a Clinical Assistant Professor since 2018. He is board-certified in Internal Medicine and Clinical Informatics and has served as Tri-Valley’s Medical Informatics Director since 2016.
In his current executive role, which began in 2024, Dr. Chu provides clinical leadership for medical staff quality, patient safety, and performance improvement. He chairs the Joint Quality Council, co-leads Unit-Based Medical Director engagement, and leads strategic work in employee engagement and physician wellness, community partnerships and health equity, and digital innovation. His responsibilities also include clinical affairs, specialty coverage planning, physician agreements, and directorships. In 2026, he became executive sponsor for Support Services II (Telecom, TDS, and BioMed) in the Highly Reliable Patient Centered Care management system launch.
Dr. Chu previously served as Associate Chief Medical Officer for Patient Safety, Infection Control, and Regulatory Compliance (2022–2024) and Vice Chief of Medicine (2021–2023). His work spans accreditation readiness, clinical documentation, transfusion safety, physician engagement, and clinical workflow redesign. He founded the Clinician Builder Program in 2019 and the Health Information Management Services Committee in 2020. His projects include telemedicine services, digital procedure consents, clinical decision support, order set optimization, and support for the Tri-Valley neurosurgery program launch planned for December 2026.
Dr. Chu is a reviewer for Applied Clinical Informatics and received the Division of Hospital Medicine’s Excellence in Interprofessional Practice Award in 2025. His professional development includes the Stanford Leadership Development Program (2024) and the Just Culture Conduct Course for Healthcare Managers & Influencers offered by The Just Culture Company (2026).
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring advancements in technology.
